Iovance Fired Another Shot Across The Bow Of CAR-T
The approval of Novartis’ (NVS) Kymriah is a “major leap forward” for oncology and immunotherapy, but there still remains “significant room for differentiated products,” H.C. Wainwright analyst Joseph Pantginis tells investors in a research note on Iovance Biotherapeutics (IOVA) titled “Pins Set Up: Kite Acquired and Kymriah Approved; TILs Can Knock ‘Em Down; Reiterate Buy.” […]
See No Evil, Speak No Evil
The Jackson Hole speeches of Janet Yellen and Mario Draghi last week were notable for the omission of any comment about the burning issues of the day: …where do the Fed and the ECB respectively think America and the Eurozone are in the central bank induced credit cycle, and therefore, what are the Fed and […]
The Overall Health Of The Gold Market
Ed D’Agostino, COO of the Hard Assets Alliance shares his views on the overall health of the gold market. We look at outside factors that play a roll in the gold market which include central bank policy, overall economic growth, and government actions. He also shares some insights into the demand for the metals from […]
End Of An Era For Jobless Claims?
Jobless claims once again came in at impressive levels this week, rising from 235K up to 236K compared to expectations for a reading of 237K. How impressive are the current low levels of jobless claims? Here are a few examples. For starters, this week’s reading was the 130 straight weekly print where claims came in […]
NZD/USD Slides Into Support – Key Levels To Know For NFP
NZD/USD Daily Chart Technical Outlook: Kiwi broke below confluence support today at 7180/88– this region is defined by the 50% retracement of the May advance & the 200-day moving average and converges on the median-line extending off the March lows. The decline is now testing interim support at the 200-day moving average / February lows at 7130 with more significant […]
Copper Charging Upward
How genuine is the copper rally? Copper rallied up to 2008 then collapsed. Video Length: 00:20:01
Real Income, Real PCE Rise 0.2 Percent In July: PCE Inflation 0.1 Percent
The Personal Income and Outlays Report from the BEA show Real DPI increased 0.2 percent in July and Real PCE increased 0.2 percent. The PCE price index increased 0.1 percent. Excluding food and energy, the PCE price index increased 0.1 percent. Personal Income and Outlays This report is consistent with GDP near two percent which is where its […]
TD Bank’s Q3 Financial Results Reflect 17% Growth In Earnings
TD Bank Group (TD) today announced its financial results for the third quarter ended July 31, 2017, reflecting: impressive earnings and revenue growth, better credit performance across all their businesses, and lower insurance claims THIRD QUARTER FINANCIAL HIGHLIGHTS (all amounts are expressed in Canadian dollars) compared with the third quarter last year: Reported earnings: UP 17% to $2.8 billion […]
Best Performing Leveraged/Inverse ETFs Of August
August has been an extremely volatile month for the global stock market. This is because heightened North Korea tensions and doubts over Trump administration triggered risk-off trade several times in the month. An uncertain Fed policy, threat of government shutdown and Hurricane Harvey also took a toll on stocks. On the other hand, strong corporate […]
AstraZeneca And Takeda Pharmaceutical Company Limited Parkinson’s Collaboration
AstraZeneca PLC (AZN) announced that it has put together a deal with Takeda Pharmaceutical Company Limited (TKPYY) that will see the two collaborate on the development of a brand-new Parkinson’s disease asset. The last week or so has been a busy period for AstraZeneca, with the company announcing the approval of its Faslodex asset as […]
